May 25, 2018 Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone
May 22, 2018 Oncolytics Biotech® Has Applied to List its Common Shares on Nasdaq and Announces Share Consolidation
May 17, 2018 Oncolytics Biotech® Announces Collaboration Between Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study
May 16, 2018 Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting
May 10, 2018 Oncolytics Biotech® Receives Special Protocol Assessment Agreement from FDA for Phase 3 Clinical Trial of Pelareorep In Metastatic Breast Cancer
May 4, 2018 Oncolytics Biotech® Announces Voting Results from its Annual General Meeting of Shareholders
